Recently, SALL2 was found downregulated in various types of cancer, including leukemia, ovarian, lung, and radioresistant esophageal cancers (Sung et al, 2013; Liu et al, 2014; Luo et al, 2017), suggesting that SALL2 may act as a tumor suppressor. This evidence concerns the gene SALL2 and neoplasm.